A Randomized Controlled Trial on the Efficacy of Tenofovir Disoproxil Fumarate (TDF)-Switch Therapy in Chronic Hepatitis B Patients With Incomplete Response to Entecavir

NCT01918631 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Chronic Heptitis B

Interventions

DRUG: tenofovir disoproxil fumarate
DRUG: Entecavir

Sponsor

Chinese University of Hong Kong